Oncology companies develop therapies, diagnostics and technologies that support the detection, monitoring and treatment of cancer. The sector is one of the largest and most active areas of biotechnology and pharmaceutical innovation.
This category includes companies working on:
Browse 291 UK oncology companies below.
Point-of-care HPV self-testing for cervical cancer screening
10zyme is an early-stage medical technology company developing a point-of-care self-test for high-risk human papillomavirus, integrating synthetic biology with machine learning to deliver instant results without laboratory processing. Its test screens for all 14 high-risk HPV types linked to cervical cancer,…
Biomarker-driven CRO integrating clinical trials and laboratory sciences
Precision for Medicine is a full-service contract research organisation built around biomarker-driven clinical development. The company integrates clinical trial execution with specialty laboratory services, translational science, data management, and biostatistics to support oncology, rare disease, and cell and gene…
Anti-cancer drug formulation and manufacturing technology development services
PTC Oncology is a contract research organisation specialising in the formulation and manufacturing technology development of anti-cancer drugs. The company supports pharmaceutical manufacturers, research centres, and academic institutions with pre-formulation studies, process design, scale-up, and analytical method…
Oncology biotech creation studio developing and spinning out cancer therapies
Cumulus Oncology is a company creation studio specialising in oncology drug discovery and development. The company identifies and sources novel cancer therapeutic assets from academic and commercial organisations, funds them, and incorporates them into newly created spin-out biotechs. Cumulus provides scientific…
Infant gut bacteria-derived therapeutic compounds
Bioscopic is a UK biotech developing therapeutic compounds derived from infant gut bacteria to treat cancer and chronic disease. It holds what it describes as the world's largest collection of infant gut bacterial strains, which it uses as a screening platform to identify biologically active compounds. Its lead…
Clinical-stage company developing treatments for cancer cachexia and muscle wasting
Actimed Therapeutics is a clinical-stage specialty pharma developing treatments for cancer cachexia and muscle wasting disorders, areas with significant unmet need and no globally approved therapies. Its lead programme has completed Phase 1 and received FDA IND approval, with a Phase 2b/3 trial planned in non-small…
Finnish pharma company marketing and developing medicines
Orion Pharma (UK) Limited is the UK subsidiary of Orion Corporation, a Finnish pharmaceutical company. The UK entity manages commercial operations for Orion's prescription medicines portfolio across therapy areas including neurology, respiratory disease, oncology and women's health. A biologics R&D centre opened at…
Academic-industry translational research institute
The Milner Therapeutics Institute is a University of Cambridge biomedical research institute established to bridge academic science and pharmaceutical drug discovery. Founded in 2015 and based at the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus, it operates both an in-house research programme and…
Cancer biotherapeutics targeting disease-specific protein isoforms
Isoform Oncology is an early-stage biotechnology company developing cancer therapeutics based on isoform switching and alternative RNA splicing. The company identifies cancer-specific protein variants arising from aberrant splicing and develops biotherapeutics designed to selectively target these disease-specific…
Quantitative pharmacology and modelling consultancy for drug development
Physiomics is a life science consultancy providing model-informed drug development, quantitative pharmacology, and biostatistics services to biopharma and biotech clients. Services include PK/PD and quantitative systems pharmacology modelling, clinical trial design, biostatistics, and personalised dosing tools. Its…
Next-generation ADC linker chemistry for precision cancer therapeutics
Siftr Bio is a biotechnology company developing novel linker chemistry for antibody-drug conjugates. Current ADC linkers have limited diversity and insufficient selectivity, contributing to off-target toxicity that restricts their therapeutic application. Siftr's platform screens enzyme-responsive linker candidates…